The latest biotechnology news | Bio News
louis-reed-pwcKF7L4-no-unsplash

CFOs oppose tax change that kills R&D incentives

A letter from 178 CFOs representing major corporations urges legislative leaders to overturn ...
Read More
cdc-y-8fqaK1kY-unsplash

Climate change exacerbates infectious diseases, studies find

Climate change has already had a massive impact on crops and agriculture, but ...
Read More
07-long-covid

Paxlovid reduces the risk of long COVID, says study

BIO member Pfizer Inc.’s antiviral drug Paxlovid, which has already been shown to ...
Read More
element5-digital-ls8Kc0P9hAA-unsplash

2022 Midterms Preview: 4 things to watch on Election Day

The midterms are here. And while the days of knowing key race results ...
Read More
pharmacist-oop-smoothing

CMS must flesh out plan to ease out-of-pocket drug costs, report says

Provisions in the Inflation Reduction Act (IRA) make it easier for people covered ...
Read More
pollution-gd3cdfa9e8_1280

COP27 to address global climate crisis and growing food demand

COP27, the U.N. Climate Change Conference, is the annual meeting of the 198 ...
Read More
Save with Avantor and BIO Business Solutions

EDITORS' CHOICE

Fritz Bittenbender

A conversation with Fritz Bittenbender, new BIO Board Chair

The exciting new developments we’re seeing in biotechnology must be supported by equally innovative policy, according to Fritz Bittenbender, the new Chair of the Board ...
Read More

LATEST NEWS

BIO Events

Startup Stadium: Tezcat Biosciences targets common cancer mutation

A Rat sarcoma (RAS) mutation is an oncogene, a gene that causes cancer when mutated. The RAS is the most commonly mutated oncogene in human ...
Federal Policy

Psoriasis awareness: The condition is more than skin deep

Over 8 million people in the U.S., and 125 million worldwide, live with psoriasis—about 2–3% of the population. Far from being a simple cosmetic condition, ...
Health

BIO 2025: As M&A slows, biotechs need to show good data

M&A in biotech has slowed from its peak in 2023 but there are still deals to be done, especially for companies who can present good ...
BIO Events

BIO 2025: How weight loss drugs are disrupting chronic disease

“Initial weight loss is just the first chapter,” said Mia de Graaf, Deputy Executive Health Editor at Business Insider, “but the real challenge and opportunity ...
BIO Events

BIO 2025: Psychedelics go mainstream – what’s next?

When experts discussed clinical uses of psychedelics two years ago at the 2023 Biotechnology Innovation Organization (BIO) International Convention, there was some interest in separating ...

Welcome, John F. Crowley!

Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.

Federal Policy

State Policy

International

Bio's View

Scroll to Top